Mucodyne

Role

Indications

Reactions

Secondary

Drug Use For Unknown Indication	15.3%
Asthma	10.1%
Product Used For Unknown Indication	7.4%
Hypertension	7.0%
Upper Respiratory Tract Inflammation	6.9%
Nasopharyngitis	6.4%
Cough	6.0%
Influenza	5.3%
Otitis Media Acute	4.5%
Cerebral Infarction	3.9%
Cholelithiasis	3.8%
Back Pain	3.4%
Bronchitis	3.0%
Pyrexia	3.0%
Prophylaxis	2.9%
Respiratory Disorder	2.7%
Sinusitis	2.3%
Chronic Obstructive Pulmonary Disease	2.2%
Pneumonia	2.1%
Idiopathic Pulmonary Fibrosis	1.8%

Tubulointerstitial Nephritis	11.5%
Liver Disorder	10.8%
Hepatic Function Abnormal	8.5%
Stevens-johnson Syndrome	8.5%
Abnormal Behaviour	7.7%
Pneumonia	6.2%
Erythema Multiforme	5.4%
Pyrexia	4.6%
Toxic Epidermal Necrolysis	4.6%
Somnolence	3.8%
Drug Eruption	3.1%
Rash	3.1%
Renal Failure Acute	3.1%
Respiratory Failure	3.1%
Thrombocytopenic Purpura	3.1%
Toxic Skin Eruption	3.1%
Vomiting	3.1%
Anaphylactic Shock	2.3%
Erythema	2.3%
Gamma-glutamyltransferase Increased	2.3%

Concomitant

Asthma	13.5%
Product Used For Unknown Indication	10.8%
Prophylaxis	8.8%
Drug Use For Unknown Indication	8.3%
Bronchitis	6.9%
Hypertension	6.0%
Rheumatoid Arthritis	5.7%
Influenza	5.2%
Pneumonia	4.5%
Nasopharyngitis	3.8%
Upper Respiratory Tract Inflammation	3.6%
Cough	3.5%
Chronic Obstructive Pulmonary Disease	3.0%
Gastritis	3.0%
Constipation	2.8%
Insomnia	2.7%
Bronchitis Chronic	2.6%
Diabetes Mellitus	2.0%
Otitis Media	1.8%
Productive Cough	1.6%

Pneumonia	10.1%
Abnormal Behaviour	9.3%
Interstitial Lung Disease	8.3%
Pyrexia	7.8%
Vomiting	7.7%
Hepatic Function Abnormal	5.4%
White Blood Cell Count Decreased	5.3%
Loss Of Consciousness	4.6%
Delirium	4.5%
Liver Disorder	4.5%
Rash	4.3%
Rhabdomyolysis	4.0%
White Blood Cell Count Increased	3.8%
Hallucination	3.3%
Renal Impairment	3.3%
Respiratory Failure	3.1%
Death	2.9%
Sepsis	2.7%
Convulsion	2.6%
Upper Respiratory Tract Inflammation	2.5%